Insulet | Betriebsaufwand



Operating Expenses Veränderung Datum
Abbott USD 9.07B 369M 2025-06
Align Technology USD 849.42M 1.25M 2025-06
AtriCure USD 142.33M 12.76M 2025-06
Avanos Medical USD 228.66M 71.46M 2025-06
Baxter International USD 2.54B 29M 2025-06
Becton, Dickinson and Co. USD 4.53B 196M 2025-06
Boston Scientific USD 4.12B 377M 2025-06
Cardinal Health USD 59.53B 5.38B 2025-06
Cooper Companies USD 817.5M 34.8M 2025-04
Dexcom USD 944.5M 42.2M 2025-06
Edwards Lifesciences USD 1.1B 83.4M 2025-06
Eli Lilly USD 8.54B 1.22B 2025-06
Globus Medical USD 1.62B 1.12B 2025-06
ICU Medical USD 522.06M 53.06M 2025-06
Insulet USD 528M 8.3M 2025-06
Integra LifeSciences USD 416.91M 18.3M 2025-06
J&J USD 16.8B 8.54B 2025-06
Masimo USD 306.4M 12.4M 2025-06
Medtronic USD 7.49B 845M 2025-04
Merit Medical Systems USD 335.44M 21.12M 2025-06
Roche Holding CHF 11.43B 1.48B 2024-12
Solventum Corp 1.95B 29M 2025-06
Stryker USD 4.85B 175M 2025-06
Tandem Diabetes Care USD 272.54M 82.76M 2025-06
Teleflex USD 603.41M 33.06M 2025-06
West Pharmaceutical Services USD 612.8M 21.8M 2025-06
Zimmer Biomet Holdings USD 1.68B 110.7M 2025-06


Insulet Betriebsaufwand - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Aug 2025.